Modulation of dopamine neuronal activity by glutamate receptor subtypes

Neuroscience and Biobehavioral Reviews

Volumn 21, Issue 4, 1997, Pages 511-518

  Meltzer, Leonard T ^a   Christoffersen, Curt L ^a   Serpa, Kevin A ^a  

^a PFIZER INC   (United States)

Author keywords

AMPA; DA neurons; Glutamate agonists; Glutamate antagonists; Glutamate receptors; Neurophysiology; NMDA; Parkinson's disease; Schizophrenia

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DOPAMINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE;

ARTICLE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ELECTROPHYSIOLOGY; FRONTAL CORTEX; NEUROMODULATION; PARKINSON DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANIMALS; DOPAMINE; HUMANS; NEURONS; RECEPTORS, GLUTAMATE;

EID: 0030993243     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(96)00030-9     Document Type: Article

References (96)

1. 1. Albin, R. L.; Makowiec, R. L.; Hollingsworth, Z. R.; Dure IV, L. S.; Penny, J. B.; Young, A. B., Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience, 46, 35-48 1985.
2. 2. Birse, E. F.; Eaton, S. A.; Jane, D. E.; Jones, P. L. S. J.; Porter, R. H. P.; Pook, P. C.-K.; Sunter, D. C.; Udvarhelyi, P. M.; Wharton, B.; Roberts, P. J.; Salt, T. E.; Watkins, J. C., Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system. Neuroscience, 52, 481-488 1993.
3. 3. Brouillet, E.; Beal, M. F., NMDA antagonists partially protect against MPTP induced neurotoxicity in mice. Neuro Report, 4, 387-390 1993.
4. 4. Bunney, B. S.; Waiters, J. R.; Roth, R. H.; Aghajanian, G. K., Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther., 195, 560-571 1973.
5. 5. Carter, C. J., Topographical distribution of possible glutamatergic pathways from the prefrontal cortex to the striatum and substantia nigra in rats. Neuropharmacology, 21, 379-383 1982.
6. 6. Catania, M. V.; de Socarraz, H.; Penney, J. B.; Young, A. B., Metabotropic glutamate 21 receptor heterogeneity in rat brain. Molec. Pharm., 45, 626-636 1994.
7. 7. Chan, P.; Langston, J. W.; Di Monte, D. A., MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP + elimination in the mouse striatum. J. Pharmacol. Exp. Ther., 267, 1515-1520 1993.
8. 8. Charlety, P. J.; Grenhoff, J.; Chergui, K.; De La Chapelle, B.; Buda, M.; Svensson, T. H.; Chouvet, G., Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynureate. Acta Physiol. Scand., 142, 105-112 1991.
9. 9. Chergui, K.; Akaoka, A.; Charlety, P. J.; Saunier, C. F.; Buda, M.; Chouvet, G., Subthalamic nucleus modulates burst firing of nigral dopamine neurons via NMDA receptors. Neuro Report, 5, 1185-1188 1994.
10. 10. Chergui, K.; Charlety, P. J.; Akoka, H.; Saunier, C. F.; Brunet, J.-L.; Buda, M.; Svensson, T. H.; Chovet, G., Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci., 5, 137-144 1993.
11. 11. Christoffersen, C. L.; Meltzer, L. T., Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors. Neuroscience, 67, 373-381 1995.
12. 12. Clark, D.; Chiodo, L. A., Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens neurons in the rat. Synapse, 2, 474-485 1988.
13. 13. Di Loreto, S.; Florio, T.; Scarnati, E., Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons. Exp. Brain Res., 89, 79-86 1992.
14. 14. Dougherty, P. M.; Palecek, J.; Paleckova, V.; Sorkin, L. S.; Willis, W. D., The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal and electrical stimuli. J. Neurosci., 12, 3025-3041 1992.
15. 15. Freeman, A. S.; Bunney, B. S., The effects of phencyclidine and N-allylnormetazoeine on midbrain dopamine neuronal activity. Eur. J. Pharmacol., 104, 287-293 1984.
16. 16. Freeman, A. S.; Bunney, B. S., Firing properties of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin. Brain Res., 405,46-55 1987.
17. 17. Freeman, A. S.; Meltzer, L. T.; Bunney, B. S., Firing properties of substantia nigra dopaminergic neurons in freely moving rats. Life Sci., 36, 1983-1994 1985.
18. 18. French, E. D., The effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat. Neuropharmacology, 25, 241-248 1986.
19. 19. French, E. D., Competitive NMDA receptor antagonists attenuate phencyclidineinduced excitations of A10 dopamine neurons. Eur. J. Pharmacol., 271, 1-7 1992.
20. 20. French, E. D.; Ceci, A., Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci. Lett., 119, 159-162 1990.
21. 21. French, E. D.; Ferkany, L.; Abreu, M.; Levenson, S., Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. Neuropharmacology, 30, 1039-1046 1991.
22. 22. French, E. D.; Mura, A.; Wang, T., MK-801, Phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists. Synapse, 13, 108-116 1993.
23. 23. Gariano, R. F.; Groves, P. M., Burst firing in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res., 462, 194-198 1988.
24. 24. Geoffroy, M.; Lambolez, B.; Audinat, E.; Hamon, B.; Crepel, F.; Rossier, J.; Kado, R. T., Reduction of sensitization of a glutamate ionotropic receptor by antagonists. Molec. Pharmacol., 39, 587-591 1989.
25. 25. Grace, A. A., Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience, 41, 1-24 1991.
26. 26. Grace, A. A.; Bunney, B. S., Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur. J. Pharmacol., 59, 211-218 1979.
27. 27. Grace, A. A.; Bunney, B. S., Intracellular and extracellular electrophysiology of nigral dopaminergic neurons - 1. Identification and characterization. Neuroscience, 10, 301-315 1983.
28. 28. Grace, A. A.; Bunney, B. S., The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci., 4, 2866-2876 1984.
29. 29. Grace, A. A.; Bunney, B. S., The control of firing pattern in nigral dopamine neurons: burst-firing. J. Neurosci., 4, 2877-2890 1984.
30. 30. Grenhoff, J.; Aston-Jones, G.; Svensson, T. H., Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol. Scand., 128, 351-358 1986.
31. 31. Groenwegen, H. J.; Berendse, H. M., Connections of the subthalamic nucleus with ventral striatopalladial parts of the basal ganglia. J. Comp. Neurol., 294, 607-622 1990.
32. 32. Gu, X.; Blatz, A. L.; German, D. C., Subtypes of substantia nigra dopaminergic neurons revealed by apamin: autoradiographic and electrophysiological studies. Brain Res. Bull., 28, 435-440 1992.
33. 33. Hammond, C.; Shibazaki, T.; Rouzaire-DuBois, B., Branched output neurons of the rat subthalarnic nucleus: electrophysiological study of the synaptic effect of identified cells in the main target nuclei, the entopeduncular nucleus and the substantia nigra. Neuroscience, 9, 511-520 1983.
34. 34. Hollmann, M.; Heinemann, S., Cloned glutamate receptors. A. Rev. Neurosci., 17, 31-108 1994.
35. 35. Huettner, J. E.; Bean, B. P., Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc. Natn. Acad. Sci., 85, 1307-1311 1988.
36. 36. Johnson, S. W.; North, R. A., Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol., 450, 455-468 1992.
37. 37. Kalivas, P. W.; Duffy, P.; Barrow, J., Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J. Pharmacol. Exp. Ther., 251, 378-387 1989.
38. 38. Kita, H.; Kitai, S. T., Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with PHA-L method. J. Comp. Neurol., 260, 435-452 1987.
39. 39. Kornhuber, J.; Kim, J.-S.; Kornhuber, M. E.; Kornhuber, H. H., The cortico-nigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res., 322, 124-126 1984.
40. 40. Kupsch, A.; Loschmann, P. A.; Sauer, H.; Arnold, G.; Renner, P.; Pufal, D.; Burg, M.; Wachtel, H.; ten-Bruggencate, G.; Oertel, W. H., Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice. Brain Res., 592, 74-83 1992.
41. 41. Lange, K. W.; Loschmann, P. A.; Sofic, E.; Burg, M.; Horowski, R.; Kalveram, K. T.; Wachtel, H.; Riederer, P., The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates. Naunyn-Schmiedebergs Arch. Pharmacol., 348, 586-592 1993.
42. 42. Ljungberg, T.; Apicella, P.; Schultz, W., Responses of monkey dopamine neurons during learning of behavioral reactions. J. Neurophysiol., 67, 145-163 1992.
43. 43. Mayer, M. L.; Westbrook, G. L., The action of N-methyl-D-aspartic acid on mouse spinal neurones in culture. J. Physiol., 361, 65-90 1985.
44. 44. Mercuri, N. B.; Stratta, F.; Calabresi, P.; Bernardi, G., A voltage-clamp analysis of NMDA-induced responses on dopaminergic neurons of the rat substantia nigra zona compacta and ventral tegmental area. Brain Res., 593, 51-56 1992.
45. 45. Mercuri, N. B.; Stratta, F.; Calabresi, P.; Bonci, A.; Bernardi, G., Activation of metabotropic glutamate receptors induces an inward current in rat mesencephalic neurons. Neuroscience, 56, 399-407 1993.
46. 46. Mereu, G.; Costa, E.; Armstrong, D. M.; Vicini, S., Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J. Neuroscience, 11, 1359-1366 1991.
47. 47. Michel, P. P.; Agid, Y., The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenyl-pyridinium ion (MPP +) in rat dissociated mesencephalic cultures. Brain Res., 597, 233-240 1992.
48. 48. Mintz, J.; Hammond, C.; Guibert, B.; Leviel, V., Stimulation of the subthalarnic nucleus enhances the release of dopamine in the rat substantia nigra. Brain Res., 376, 406-408 1986.
49. 49. Murase, S.; Grenhoff, J.; Chouvet, G.; Gonon, F. G.; Svensson, T. H., Prefrontal cortex burst firing and transmitter release in rat mesolimbic dopamine neurons studies in vivo. Neurosci. Lett., 157, 53-56 1993.
50. 50. Nakanishi, S., Molecular diversity of glutamate receptors and implications for brain function. Science, 258, 597-603 1992.
51. 51. Overton, P.; Clark, D., Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst-firing in A9 dopamine neurons in the rat. Synapse, 10, 131-140 1992.
52. 52. Pateneau, D. K.; Mayer, M. L., Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J. Neuroscience, 10, 2385-2399 1990.
53. 53. Pateneau, D. K.; Mayer, M. L., Kinetic analysis of interactions between kainate and AMPA: evidence for activation of a single receptor in mouse hippocampal neurons. Neuron, 6, 785-798 1991.
54. 54. Pawlowski, L.; Mathe, J. M.; Svensson, T. H., Phencyclidine activates A10 dopamine neurons but reduces burst firing activity and causes regularization of firing. Acta Physiol. Scand., 139, 529-530 1990.
55. 55. Pin, J.-P.; Duvoisin, R., Review: Neurotransmitters I. The metabotropic glutamate receptors: structure and functions. Neuropharmacology, 34, 1-26 1995.
56. 56. Rinvik, E.; Ottersen, O. P., Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: an electron microscopic, immunogold analysis in the cat. J. Chem. Neuroanat., 6, 19-30 1993.
57. 57. Robledo, P.; Féger, J., Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res., 518, 47-54 1990.
58. 58. Rosales, M. G.; Floers, G.; Hernandez, S.; Martinez-Fong, D.; Aceves, J., Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Brain. Res., 645, 335-337 1994.
59. 59. Sah, P.; Hestrin, S.; Nicoll, R. A., Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science, 246, 815-818 1989.
60. 60. Salt, T. E., Excitatory amino acid receptors and synaptic transmission in the rat ventrobasal thalamus. J. Physiol., 391, 499-510 1987.
61. 61. Salt, T. E.; Eaton, S. A., Sensory excitatory postsynaptic potentials mediated by NMDA and non-NMDA receptors in the thalamus in vivo. Eur. J. Neurosci., 3, 296-300 1991.
62. 62. Sands, S. B.; Barish, M. E., A quantitative description of excitatory amino acid neurotransmitter responses on cultured embryonic Xenopus spinal neurons. Brain Res., 502, 375-386 1989.
63. 63. Sanghera, M. K.; Trulson, M. E.; German, D. C., Electrophysiological properties of mouse dopamine neurons: in vivo and in vitro studies. Neuroscience, 12, 793-801 1984.
64. 64. Sather, W.; Johnson, J. W.; Henderson, G.; Ascher, P., Glycine-insensitive desensitization of NMDA responses in cultured mouse embryonic neurons. Neuron, 4, 725-731 1990.
65. 65. Scarnati, E.; Proia, A.; Campana, E.; Pacitti, C., A microiontophoretic study on the nature of the putative synaptic neurotransmitter involved in the pedunculopontine-substantia nigra pars compacta excitatory pathway of the rat. Exp. Brain Res., 62, 470-478 1986.
66. 66. Schneggenburger, R.; Zhou, Z.; Konnerth, A.; Neher, E., Fractional contribution of calcium to the cation current through glutamate receptor channels. Neuron, 11, 133-143 1993.
67. 67. Schultz, W., Behavior-related activity of primate dopamine neurons. Rev. Neurol. Paris, 150, 634-639 1994.
68. 68. Schoepp, D. D.; Conn, P. J., Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci., 14, 13-20 1993.
69. 69. Sesack, S. R.; Pickel, V. M., Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamines in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol., 320, 145-160 1992.
70. 70. Seutin, V.; Johnson, S. W.; North, R. A., Apamin increases NMDA-induced burst-firing of rat mesencephalic dopamine neurons. Brain Res., 630, 341-344 1993.
71. 71. Seutin, V.; Verbank, P.; Massotte, L.; Dresse, A., Evidence for the presence of N-methyl-D-aspartate receptors in the ventral tegmental area of the rat: an electrophysiological study. Brain Res., 514, 147-150 1990.
72. 72. Shepard, P. D.; Bunney, B. S., Effects of apamin on the discharge properties of putative dopamine-containing neurons in vitro. Brain Res., 463, 380-384 1988.
73. 73. Shepard, P. D.; Lehmann, H., (±)-1-Hydroxy-3-aminopyrrolidone-2 (HA-966) inhibits the activity of substantia nigra dopamine neurons through a non-N-methyl-D-aspartate receptor-mediated mechanism. J. Pharmacol. Exp. Ther., 261, 387-394 1992.
74. 74. Silva, N. L.; Bunney, B. S., Intracellular studies of dopamine neurons in vitro: pacemakers modulated by dopamine. Eur. J. Pharmacol., 149, 307-315 1988.
75. 75. Skirboll, L. R.; Grace, A. A.; Hommer, D. W.; Rehfeld, J.; Goldstein, M.; Hokfelt, T.; Bunney, B. S., Peptide-monoamine coexistence: studies of the actions of cholecystokininlike peptide on the electrical activity of midbrain dopamine neurons. Neuroscience, 11, 2111-2124 1981.
76. 76. Smith, I. D.; Grace, A. A., Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse, 12, 287-303 1992.
77. 77. Sonsalla, P. K.; Zeevalk, G. D.; Manzino, L.; Giovanni, A.; Nicklas, W. J., MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J. Neurochem., 58, 1979-1982 1992.
78. 78. Standaert, D. G.; Testa, C. M.; Young, A. B.; Penney, J. B. Jr, Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J. Comp. Neurol., 343, 1-16 1994.
79. 79. Suaud-Chagny, M. F.; Chergui, K.; Chouvet, G.; Gonon, F., Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience, 49, 63-72 1992.
80. 80. Srivastava, R.; Brouillet, E.; Beal, M. F.; Storey, E.; Hyman, B. T., Blockade of 1-methyl-4-phenylpyridinium ion (MPP +) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss. Neurobiol. Aging, 14, 295-301 1993.
81. 81. Tabatabaei, A.; Perry, T. L.; Hansen, S.; Krieger, C., Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice. Neurosci. Lett., 141, 192-194 1992.
82. 82. Taber, M. T.; Das, S.; Fibiger, H. C., Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J. Neurochem., 65, 1407-1410 1995.
83. 83. Testa, C. M.; Standaert, D. G.; Young, A. B.; Penney, J. B. Jr, Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci., 14, 3005-3018 1994.
84. 84. Tokuno, H.; Moffizumi, T.; Kudo, M.; Nakamura, Y., A morphological evidence for monosynaptic projections from the nucleus pedunculopontis pars compacta (TPC) to nigrostriatal projection neurons. Neurosci. Lett., 85, 1-4 1988.
85. 85. Turski, L.; Bressler, K.; Rettig, K. J.; Loschmann, P. A.; Wachtel, H., Protection of substantia nigra from MPP + neurotoxicity by N-methyl-D-aspartate antagonists. Nature, 349, 414-418 1991.
86. 86. Ugedo, L.; Grenhoff, J.; Svensson, T. H., Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons in the rat ventral tegmental area in vivo. Psychopharmacology, 98, 45-50 1989.
87. 87. Usunoff, K. G.; Romansky, K. V.; Malinov, G. B.; Ivanov, D. P.; Blagov, Z. A.; Galabov, G. P., Electron microscopic evidence for the existence of a corticonigral tract in the cat. J. Hirnforsch., 23, 23-29 1982.
88. 88. Verdoorn, T. A.; Kleckner, N. W.; Dingledine, R., N-Methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology. Molec. Pharmacol., 35, 360-368 1989.
89. 89. Wang, T.; French, E. D., Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Synapse, 13, 270-277 1993.
90. 90. Wang, T.; French, E. D., L-Glutamate excitation of A10 dopamine neurons is preferentially mediated by activation of NMDA receptors: extra-and intracellular electrophysiological studies in brain slices. Brain Res., 627, 299-306 1993.
91. 91. Wang, T.; O'Connor, W. T.; Ungerstedt, U.; French, E. D., N-methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurons in the ventral tegmental area: in vivo microdialysis and in vitro electrophysiological studies. Brain Res., 222, 255-262 1994.
92. 92. Willetts, J.; Balster, R. L.; Leander, J. D., The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci., 11, 423-428 1990.
93. 93. Wu, H.-Q.; Schwarz, R.; Shepard, P. D., Excitatory amino-acid excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid. Synapse, 16, 219-230 1994.
94. 94. Zhang, J.; Chiodo, L. A.; Freeman, A. S., Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res., 590, 153-163 1992.
95. 95. Zhang, J.; Chiodo, L. A.; Freeman, A. S., Effects of phencyclidine, MK-801 and 1,3 di(2-tolyl)guanindine on non-dopaminergic midbrain neurons. Eur. J. Pharmacol., 230, 371-374 1993.
96. 96. Zhang, J.; Chiodo, L. A.; Freeman, A. S., Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in the rat substantia nigra. J. Pharmacol. exp. Ther., 269, 313-321 1994.